CAMPBELL, Calif., Aug. 07, 2017 -- Saama Technologies, Inc., a leading big data and advanced analytics solutions company, announced that Christine Poon, a life sciences industry luminary, is going to be a member of their Board of Advisors.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5196b4b9-477d-4819-bbfd-1495c0a56b3e
Christine Poon is the former Vice Chairman of Johnson & Johnson’s Board of Directors and former Worldwide Chairman of its Medicines & Nutritionals division. Under her leadership, Johnson & Johnson’s pharmaceutical business went through its fastest growth period, becoming the fourth biggest pharmaceutical company in the world. Prior to Johnson & Johnson, Christine was with Bristol-Myers Squibb for 15 years. Ms. Poon has degrees in Biology from St. Louis University and Northwestern as well as an MBA in Finance from the Boston University.
Christine’s business skills and passion for improving lives are held in high regard by the entire life sciences industry.
Christine said, “I look forward to taking on new challenges and discovering opportunities, especially those that involve keeping the society healthy by developing solutions powered by science and technology. Every day that a life-saving drug is delayed costs us precious lives. When we use technology to put the data we have to good use, especially to give us the necessary insights quickly, we not only get that life-saving drug to the marker faster, but also produce a better product. This is why I am happy to be associated with Saama and look forward to contributing to their growing set of data analytics offering for the Life Sciences industry.”
Founder and CEO of Saama Technologies, Suresh Katta said, “We are delighted to have Christine Poon on board. She brings deep knowledge of the industry and is sure to be an asset for us from both strategic and operational aspects. She is passionate about finding technology solutions that can advance the efforts of the life sciences industry. We welcome her perspective and are looking forward to working with someone of her stature.”
With Christine Poon on board, Saama sharpens its life sciences focus and dials up its commitment for providing data management and analytics solutions to organizations by turning their data into a source of actionable intelligence and business insights.
About Saama
Saama Technologies is the advanced data and analytics company delivering actionable business insights for life sciences, and the Global 2000. We are singularly focused on driving fast, flexible, impactful business outcomes for our clients through data and analytics. Our unique “hybrid” approach integrates focused solutions and expertise across the life sciences domain, business consulting, data science, automated data management and big data technologies. We blend manual and disconnected initiatives into a well-aligned roadmap facilitating the client’s journey from strategy through solution implementation.
Media Contact Crystal Black [email protected] 408-426-3935


Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



